IGF::OT::IGF THE DEVELOPMENT LEADING TO THE COMMERCIALIZATION OF A BIORESORBABLE STENTS (BRS) FOR THE TREATMENT OF COARCTATION OF THE AORTA (COA) IN NEONATES.

Department of Health and Human Services — National Institutes of Health

Share:

Award Amount

$3,399,279

Period of Performance

2016-09-26 — 2022-03-22

Classification

Place of Performance

N/A

Recipient

xxxxxxxxxxxxxxxxxxxxxxxxx

xxxxxxxxxxxxxxxxxxxx

Description

xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

Want to see who won this contract?

Recipient names, UEI numbers, descriptions, and contact info are available with a free account.

Need bulk access, alerts, or API?

Export data, set up opportunity alerts, and access our API with a paid plan.

View Plans →

Source: usaspending · ID: HHSN268201600038C